Authors:
Byrnes, AA
Ma, XJ
Cuomo, P
Park, K
Wahl, L
Wolf, SF
Zhou, HF
Trinchieri, G
Karp, CL
Citation: Aa. Byrnes et al., Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity, EUR J IMMUN, 31(7), 2001, pp. 2026-2034
Authors:
Swiniarski, H
Wolf, SF
Sturmhoefel, K
Peterson, RL
Dorner, AJ
O'Toole, M
Citation: H. Swiniarski et al., IL-12-dependent enhancement of CTL response to weak class I-restricted peptide immunogens requires coimmunization with T helper cell immunogens, CLIN IMMUNO, 94(3), 2000, pp. 200-211
Authors:
Lee, K
Overwijk, WW
O'Toole, M
Swiniarski, H
Restifo, NP
Dorner, AJ
Wolf, SF
Sturmhoefel, K
Citation: K. Lee et al., Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses, J INTERF CY, 20(6), 2000, pp. 589-596
Citation: Wl. Ebert et Sf. Wolf, An interlaboratory study of a standard glass for acceptance testing of low-activity waste glass, J NUCL MAT, 282(2-3), 2000, pp. 112-124
Authors:
Swiniarski, H
Sturmhoefel, K
Lee, K
Gray, GS
Thomas, JL
Wolf, SF
Dorner, AJ
O'Toole, M
Citation: H. Swiniarski et al., Immune response enhancement by in vivo administration of B7.21g, a solublecostimulatory protein, CLIN IMMUNO, 92(3), 1999, pp. 235-245
Citation: Ms. Wang et al., Chemical studies of H chondrites-10: Contents of thermally labile trace elements are unaffected by late heating, METEORIT PL, 34(5), 1999, pp. 713-716
Authors:
Shrayer, DP
Cole, B
Hearing, VJ
Wolf, SF
Wanebo, HJ
Citation: Dp. Shrayer et al., Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12, CLIN EXP M, 17(1), 1999, pp. 63-70
Authors:
Schopf, LR
Bliss, JL
Lavigne, LM
Chung, CL
Wolf, SF
Sypek, JP
Citation: Lr. Schopf et al., Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response, INFEC IMMUN, 67(5), 1999, pp. 2166-2171
Authors:
Sturmhoefel, K
Lee, K
Gray, GS
Thomas, J
Zollner, R
O'Toole, M
Swiniarski, H
Dorner, A
Wolf, SF
Citation: K. Sturmhoefel et al., Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant, CANCER RES, 59(19), 1999, pp. 4964-4972